Literature DB >> 12892713

Myeloproliferative stem cell disorders by deregulated Rap1 activation in SPA-1-deficient mice.

Daisuke Ishida1, Kohei Kometani, Hailin Yang, Kiyokazu Kakugawa, Kyoko Masuda, Kazuhiro Iwai, Misao Suzuki, Shigeyoshi Itohara, Tatsutoshi Nakahata, Hiroshi Hiai, Hiroshi Kawamoto, Masakazu Hattori, Nagahiro Minato.   

Abstract

SPA-1 (signal-induced proliferation-associated gene-1) is a principal Rap1 GTPase-activating protein in hematopoietic progenitors. SPA-1-deficient mice developed a spectrum of myeloid disorders that resembled human chronic myelogenous leukemia (CML) in chronic phase, CML in blast crisis, and myelodysplastic syndrome as well as anemia. Preleukemic SPA-1-deficient mice revealed selective expansion of marrow pluripotential hematopoietic progenitors, which showed abnormal Rap1GTP accumulation. Overexpression of an active form of Rap1 promoted the proliferation of normal hematopoietic progenitors, while SPA-1 overexpression markedly suppressed it. Furthermore, restoring SPA-1 gene in a SPA-1-deficient leukemic blast cell line resulted in the dissolution of Rap1GTP accumulation and concomitant loss of the leukemogenicity in vivo. These results unveiled a role of Rap1 in myeloproliferative stem cell disorders and a tumor suppressor function of SPA-1.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12892713     DOI: 10.1016/s1535-6108(03)00163-6

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  47 in total

1.  Self-association mediated by the Ras association 1 domain of AF6 activates the oncogenic potential of MLL-AF6.

Authors:  Michaela Liedtke; Paul M Ayton; Tim C P Somervaille; Kevin S Smith; Michael L Cleary
Journal:  Blood       Date:  2010-04-15       Impact factor: 22.113

Review 2.  Regulation of immune cell adhesion and migration by regulator of adhesion and cell polarization enriched in lymphoid tissues.

Authors:  Tatsuo Kinashi; Koko Katagiri
Journal:  Immunology       Date:  2005-10       Impact factor: 7.397

3.  Sipa1 is a candidate for underlying the metastasis efficiency modifier locus Mtes1.

Authors:  Yeong-Gwan Park; Xiaohong Zhao; Fabienne Lesueur; Douglas R Lowy; Mindy Lancaster; Paul Pharoah; Xiaolan Qian; Kent W Hunter
Journal:  Nat Genet       Date:  2005-09-04       Impact factor: 38.330

4.  Rap1GAP inhibits tumor growth in oropharyngeal squamous cell carcinoma.

Authors:  Zhaocheng Zhang; Raj S Mitra; Bradley S Henson; Nabanita S Datta; Laurie K McCauley; Pawan Kumar; Julia S-J Lee; Thomas E Carey; Nisha J D'Silva
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

5.  Histone deacetylase inhibitors upregulate Rap1GAP and inhibit Rap activity in thyroid tumor cells.

Authors:  Xiaoyun Dong; Christopher Korch; Judy L Meinkoth
Journal:  Endocr Relat Cancer       Date:  2011-04-02       Impact factor: 5.678

6.  Downregulation of Rap1GAP in human tumor cells alters cell/matrix and cell/cell adhesion.

Authors:  Oxana M Tsygankova; Changqing Ma; Waixing Tang; Christopher Korch; Michael D Feldman; Yu Lv; Marcia S Brose; Judy L Meinkoth
Journal:  Mol Cell Biol       Date:  2010-05-03       Impact factor: 4.272

7.  RapGEF2 is essential for embryonic hematopoiesis but dispensable for adult hematopoiesis.

Authors:  Ande Satyanarayana; Kristbjorn Orri Gudmundsson; Xiu Chen; Vincenzo Coppola; Lino Tessarollo; Jonathan R Keller; Steven X Hou
Journal:  Blood       Date:  2010-07-01       Impact factor: 22.113

Review 8.  Multiple roles of Rap1 in hematopoietic cells: complementary versus antagonistic functions.

Authors:  Philip J S Stork; Tara J Dillon
Journal:  Blood       Date:  2005-08-02       Impact factor: 22.113

9.  Crk and CrkL adaptor proteins: networks for physiological and pathological signaling.

Authors:  Raymond B Birge; Charalampos Kalodimos; Fuyuhiko Inagaki; Shinya Tanaka
Journal:  Cell Commun Signal       Date:  2009-05-10       Impact factor: 5.712

10.  Rap signaling in normal lymphocyte development and leukemia genesis.

Authors:  Nagahiro Minato
Journal:  Immune Netw       Date:  2009-04-30       Impact factor: 6.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.